A distinct isoform of lymphoid enhancer binding factor 1 (LEF1) epigenetically restricts EBV reactivation to maintain viral latency.
As a human tumor virus, EBV is present as a latent infection in its associated malignancies where genetic and epigenetic changes have been shown to impede cellular differentiation and viral reactivation. We reported previously that levels of the Wnt signaling effector, lymphoid enhancer binding fact...
Main Authors: | B J H Ward, Kanchanjunga Prasai, Danielle L Schaal, Jian Wang, Rona S Scott |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-12-01
|
Series: | PLoS Pathogens |
Online Access: | https://doi.org/10.1371/journal.ppat.1011873 |
Similar Items
-
EBV Association with Lymphomas and Carcinomas in the Oral Compartment
by: B. J. H. Ward, et al.
Published: (2022-12-01) -
Lef1 expression in fibroblasts maintains developmental potential in adult skin to regenerate wounds
by: Quan M Phan, et al.
Published: (2020-09-01) -
The transcription factor LEF1 interacts with NFIX and switches isoforms during adult hippocampal neural stem cell quiescence
by: Laura García-Corzo, et al.
Published: (2022-07-01) -
EBV epigenetically suppresses the B cell-to-plasma cell differentiation pathway while establishing long-term latency.
by: Christine T Styles, et al.
Published: (2017-08-01) -
EBV Reactivation from Latency Is a Degrading Experience for the Host
by: Alejandro Casco, et al.
Published: (2023-03-01)